KP Tissue Inc.
KPT.TOTSXConsumer Defensive● Active
$13.07
+$0.17(+1.32%)
Market Cap$130991461
P/E Ratio—
52W High$13.24
52W Low$8.73
KP Tissue Inc.（KPT.TO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KPT.TO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.00B | ($0.00B) | ($0.01B) | $0.00B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | ($0.00B) | $0.00B |
| Net Income | $0.00B | ($0.00B) | ($0.01B) | $0.00B | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.24 | $-0.50 | $-1.03 | $0.13 | $-0.20 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.26B | $0.24B | $0.12B | $0.15B | $0.20B |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CAD · B
深入了解KP Tissue Inc.
关于KP Tissue Inc.（KPT.TO）损益表
KP Tissue Inc.（KPT.TO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，KPT.TO实现营收$0.00B，毛利润$0.00B（毛利率—），净利润$0.00B（净利率—）。
常见问题
KPT.TO · 4 问KP Tissue Inc.（KPT.TO）2024财年营收为$0.00B，同比down—%。
KPT.TO revenueKPT.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08